Tumour protein p53‐inducible nuclear protein 1 (TP 53 INP 1) is a tumour suppressor
associated with malignant tumour metastasis. Vasculogenic mimicry (VM) is a new tumour …

Ovarian cancer is a silent killer, and shows early extensive tumor invasion and peritoneal
metastasis. The microcirculation of most tumors includes cooperation of pre-existing vessels …

Background Gastric cancer (GC) is one of the most lethal malignant tumors worldwide with
poor outcomes. Vascular mimicry (VM) is an alternative blood supply to tumors that is …

Background and aim Vasculogenic mimicry (VM) is one of the most important causes of
breast cancer metastasis and resistance against drugs. The cancer stem cells (CSCs) are …

Vasculogenic mimicry (VM) refers to the unique capability of aggressive tumor cells to mimic
the pattern of embryonic vasculogenic networks. In the study we demonstrated that CD133 …

Background Vasculogenic mimicry (VM), as a new blood supply for tumor growth and
hematogenous metastases, has been recently described in highly aggressive human …

Small cell lung cancer (SCLC) is characterized by prevalent circulating tumour cells (CTCs),
early metastasis and poor prognosis. We show that SCLC patients (37/38) have rare CTC …

In solid tumors, vascular structure and function varies from the core to the periphery. This
structural heterogeneity has been proposed to influence the mechanisms by which tumor …

Background: The concepts of vasculogenic mimicry and mosaic vessels have been
proposed as novel modes of tumour neovascularisation. However, the presence and …

Abstract In 1999, the American Journal of Pathology published an article, entitled “Vascular
channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry” by …